Overview

Pawel Muranski, MD, trained as a Hematologist and Oncologist at the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) in Bethesda, Maryland where he subsequently worked as a faculty in the Stem Cell Allogeneic Transplantation Section. He joined Columbia University in 2017 as the Director of Cellular Immunotherapy. Dr. Muranski specializes in bone marrow transplant (BMT).

Areas of Expertise / Conditions Treated

  • Bone Marrow Transplantation
  • Leukemia
  • Lymphoma

Academic Appointments

  • Assistant Professor of Medicine at CUMC

Administrative Titles

  • Director of Cellular Immunotherapy Laboratory
  • Principal Investigator at the Columbia Center for Translational Immunology (CCTI)

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

161 Fort Washington Avenue
New York, NY 10032

Insurance Accepted

Aetna

Affinity Health Plan

Amida Care

Cigna

Emblem/GHI

Emblem/HIP

Empire Blue Cross/Blue Shield

Empire Blue Cross Blue Shield HealthPlus

Fidelis Care

Healthfirst

Local 1199

MagnaCare (National)

Medicare

Multiplan

MVP Health Care

RiverSpring

UnitedHealthcare

VNSNY CHOICE

WellCare

World Trade Center Health Plan

*Before your appointment, please contact the doctor’s office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.

Credentials & Experience

Education & Training

  • MD, Medical University of Warsaw, Poland
  • Residency: AMITA Health / Saint Francis Hospital, Evanston, Illinois
  • Fellowship: National Institutes of Health (NIH), Bethesda, Maryland,
  • Fellowship: National Cancer Institute (NCI), Bethesda, MD

Committees, Societies, Councils

  • Member, Herbert Irving Comprehensive Cancer Center

Board Certifications

  • Internal Medicine
  • Hematology

Honors & Awards

  • 2025: Agilent Research Catalyst (ARC) Award

Research

At NHLBI, Dr. Muranski has conducted studies on using T cells for prevention and treatment of common viral infections affecting bone marrow transplant recipients. He has also developed first-in-human study of adoptive immunotherapy for patients with JC virus-associated Progressive Multifocal Leukoencephalopathy (PML). In addition, he has completed a research fellowship in cancer immunology and immunotherapy at the Surgery Branch, National Cancer Institute, NIH.

He is a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center. His laboratory focuses on developing potent T lymphocytes for adoptive immunotherapy of viral infections and cancer.

Research Interests

  • Cancer
  • Cellular Immunotherapy
  • Immunology
  • Immunotherapy
  • Progressive Multifocal Leukoencephalopathy (PML)
  • T Cells
  • Transplant Immunology
  • Viral Infections